bluebird bio to Present New Gene Therapy Data at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition
Go back to bluebird bio to Present New Gene Therapy Data at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition| BLUEBIRD BIO (NASDAQ: BLUE) | Delayed: 4.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.97 | 52 Week High | $95.28 | |||
| Open | $4.97 | 52 Week Low | $35.37 | |||
| Day High | $4.97 | P/E | N/A | |||
| Day Low | $4.97 | EPS | $-1.81 | |||
| Volume | 1,312,566 | |||||
